MedPath

Green Coffee Extract and Metabolic Syndrome

Phase 2
Completed
Conditions
Metabolic Syndrome
Interventions
Dietary Supplement: placebo
Dietary Supplement: green coffee extract
Registration Number
NCT02764957
Lead Sponsor
National Nutrition and Food Technology Institute
Brief Summary

Metabolic syndrome (Mets) is an assemblage of risk factors which can increase the risk of developing type 2 diabetes mellitus and cardiovascular disease. Green coffee extract (GCE) is derived from unroasted coffee beans and has substantial amounts of polyphenols primarily chlorogenic acids (CGA). It has been shown that GCE and CGA can exert a positive influence over Mets components including blood pressure, blood glucose, inflammation, oxidative stress, insulin resistance and blood lipids. Up to our knowledge no study has been conducted on humans in the field of GCA influences on Mets patients. Therefore, this study is planned to evaluate GCA supplementation effects on anthropometric measurements, glycemic control, blood pressure, lipid profile in patients with metabolic syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria
  • Waist circumference>102 cm in men and >88 cm in women
  • Fasting blood glucose>100 mg/dL (5.6 mmol /L)
  • Systolic blood pressure>130 mmHg or diastolic blood pressure>85mmHg
  • Triglycerides> 150 mg/dL (1.7 mmol/L)
Exclusion Criteria
  • Insulin administration
  • Pregnancy and breastfeeding
  • regular consumption of coffee and green tea

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controlplaceboplacebo capsules twice per day for 8 weeks have identical appearance to Green coffee extract capsules and contain starch
interventiongreen coffee extract400 mg green coffee extract capsules twice per day for 8 weeks The Green coffee extract is standardised with 45% total chlorogenic acid by HPLC
Primary Outcome Measures
NameTimeMethod
fasting blood glucose8 weeks
Secondary Outcome Measures
NameTimeMethod
HOMA-IR8 weeks
blood pressure8 weeks
insulin8 weeks
hemoglubin A1c8 weeks
triglyceride8 weeks

Trial Locations

Locations (1)

NNFTRI clinic

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath